Jakub Baudys

2.3k total citations
33 papers, 919 citations indexed

About

Jakub Baudys is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jakub Baudys has authored 33 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Neurology, 16 papers in Cellular and Molecular Neuroscience and 7 papers in Molecular Biology. Recurrent topics in Jakub Baudys's work include Botulinum Toxin and Related Neurological Disorders (21 papers), Neurological disorders and treatments (19 papers) and Hereditary Neurological Disorders (9 papers). Jakub Baudys is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (21 papers), Neurological disorders and treatments (19 papers) and Hereditary Neurological Disorders (9 papers). Jakub Baudys collaborates with scholars based in United States, Argentina and Switzerland. Jakub Baudys's co-authors include John R. Barr, Suzanne R. Kalb, Dongxia Wang, Theresa J. Smith, Dennis J. Crouch, James L. Pirkle, Leonard A. Smith, Ola M. Saad, Surinder Kaur and Joseph Walsh and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Jakub Baudys

33 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jakub Baudys United States 19 422 303 278 213 157 33 919
Mark A. Breidenbach United States 11 372 0.9× 183 0.6× 329 1.2× 33 0.2× 50 0.3× 11 738
Tsutomu Kamiyama Japan 18 148 0.4× 110 0.4× 320 1.2× 17 0.1× 28 0.2× 44 1.1k
Robert G. Stafford United States 16 596 1.4× 246 0.8× 334 1.2× 10 0.0× 77 0.5× 24 843
Robert Hopewell Canada 12 55 0.1× 64 0.2× 451 1.6× 100 0.5× 98 0.6× 25 878
Rebeca Tarrab‐Hazdai Israel 15 294 0.7× 67 0.2× 217 0.8× 127 0.6× 53 0.3× 32 732
Suzanne Ackloo Canada 17 36 0.1× 54 0.2× 432 1.6× 49 0.2× 77 0.5× 33 756
Mônica S. Freitas Brazil 12 114 0.3× 45 0.1× 287 1.0× 12 0.1× 61 0.4× 15 570
Daniel A. Boroff United States 15 524 1.2× 137 0.5× 186 0.7× 15 0.1× 39 0.2× 38 680
Wanchao Yin China 18 17 0.0× 312 1.0× 673 2.4× 94 0.4× 43 0.3× 27 1.1k
W. Mei Kok Australia 14 22 0.1× 61 0.2× 448 1.6× 50 0.2× 61 0.4× 20 729

Countries citing papers authored by Jakub Baudys

Since Specialization
Citations

This map shows the geographic impact of Jakub Baudys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Baudys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Baudys more than expected).

Fields of papers citing papers by Jakub Baudys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Baudys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Baudys. The network helps show where Jakub Baudys may publish in the future.

Co-authorship network of co-authors of Jakub Baudys

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Baudys. A scholar is included among the top collaborators of Jakub Baudys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Baudys. Jakub Baudys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zijian, Jakub Baudys, Christopher A. Haynes, et al.. (2024). Enhanced Surface Accessibility of SARS-CoV-2 Omicron Spike Protein Due to an Altered Glycosylation Profile. ACS Infectious Diseases. 10(6). 2032–2046. 4 indexed citations
2.
Wang, Dongxia, Bin Zhou, Theodore R. Keppel, et al.. (2021). N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry. Scientific Reports. 11(1). 23561–23561. 12 indexed citations
3.
Kalb, Suzanne R., et al.. (2019). Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay. Journal of Analytical Toxicology. 44(2). 173–179. 5 indexed citations
4.
Kalb, Suzanne R., Jakub Baudys, Theresa J. Smith, Leonard A. Smith, & John R. Barr. (2017). Characterization of Hemagglutinin Negative Botulinum Progenitor Toxins. Toxins. 9(6). 193–193. 15 indexed citations
5.
Wang, Dongxia, et al.. (2017). Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry. Analytical and Bioanalytical Chemistry. 409(20). 4779–4786. 13 indexed citations
6.
Kalb, Suzanne R., Jakub Baudys, Dongxia Wang, & John R. Barr. (2015). Recommended Mass Spectrometry-Based Strategies to Identify Botulinum Neurotoxin-Containing Samples. Toxins. 7(5). 1765–1778. 35 indexed citations
7.
Kalb, Suzanne R., Jakub Baudys, & John R. Barr. (2015). Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry. BMC Microbiology. 15(1). 227–227. 5 indexed citations
8.
Wang, Dongxia, et al.. (2015). Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates. Bioorganic & Medicinal Chemistry. 23(13). 3667–3673. 20 indexed citations
9.
Dere, Randall, Joo‐Hee Yi, Ola M. Saad, et al.. (2013). PK Assays for Antibody–Drug Conjugates: Case Study with Ado-Trastuzumab Emtansine. Bioanalysis. 5(9). 1025–1040. 50 indexed citations
10.
Wang, Dongxia, Sabine Pellett, Jakub Baudys, et al.. (2013). Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834(12). 2722–2728. 24 indexed citations
11.
Wang, Dongxia, Jakub Baudys, Yiming Ye, et al.. (2012). Improved detection of botulinum neurotoxin serotype A by Endopep–MS through peptide substrate modification. Analytical Biochemistry. 432(2). 115–123. 15 indexed citations
12.
Kalb, Suzanne R., Jakub Baudys, Jon C. Rees, et al.. (2012). De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Analytical and Bioanalytical Chemistry. 403(1). 215–226. 42 indexed citations
13.
Wang, Dongxia, Jakub Baudys, Jon C. Rees, et al.. (2012). Subtyping Botulinum Neurotoxins by Sequential Multiple Endoproteases In-Gel Digestion Coupled with Mass Spectrometry. Analytical Chemistry. 84(11). 4652–4658. 14 indexed citations
14.
Wang, Dongxia, Jakub Baudys, Suzanne R. Kalb, & John R. Barr. (2011). Improved detection of botulinum neurotoxin type A in stool by mass spectrometry. Analytical Biochemistry. 412(1). 67–73. 35 indexed citations
15.
Kalb, Suzanne R., Jakub Baudys, Robert Webb, et al.. (2011). Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Letters. 586(2). 109–115. 49 indexed citations
16.
Xu, Keyang, Luna Liu, Ola M. Saad, et al.. (2011). Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry. Analytical Biochemistry. 412(1). 56–66. 122 indexed citations
17.
Kalb, Suzanne R., Consuelo Garcia-Rodriguez, Jianlong Lou, et al.. (2010). Extraction of BoNT/A, /B, /E, and /F with a Single, High Affinity Monoclonal Antibody for Detection of Botulinum Neurotoxin by Endopep-MS. PLoS ONE. 5(8). e12237–e12237. 44 indexed citations
18.
Leipold, Douglas D., Jakub Baudys, Ola M. Saad, et al.. (2007). Development of a pharmacokinetic model examining trastuzumab-MCC-DM1, MCC-DM1 and DM1 in normal rats. Molecular Cancer Therapeutics. 6. 1 indexed citations
19.
Wilkins, Diana G., Jakub Baudys, Dennis J. Crouch, et al.. (2005). Age-Dependent Methamphetamine-Induced Alterations in Vesicular Monoamine Transporter-2 Function: Implications for Neurotoxicity. Journal of Pharmacology and Experimental Therapeutics. 314(3). 1087–1092. 56 indexed citations
20.
Crouch, Dennis J., et al.. (2005). An Evaluation of Selected Oral Fluid Point-of-Collection Drug-Testing Devices. Journal of Analytical Toxicology. 29(4). 244–248. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Breidenbach Breakdown of academic impact, for papers by Tsutomu Kamiyama Breakdown of academic impact, for papers by Robert G. Stafford Breakdown of academic impact, for papers by Robert Hopewell Breakdown of academic impact, for papers by Rebeca Tarrab‐Hazdai Breakdown of academic impact, for papers by Suzanne Ackloo Breakdown of academic impact, for papers by Mônica S. Freitas Breakdown of academic impact, for papers by Daniel A. Boroff Breakdown of academic impact, for papers by Wanchao Yin Breakdown of academic impact, for papers by W. Mei Kok
Rankless by CCL
2026